1. Immune evasion of Enterococcus faecalis by an extracellular gelatinase that cleaves C3 and iC3b.
- Author
-
Park SY, Shin YP, Kim CH, Park HJ, Seong YS, Kim BS, Seo SJ, and Lee IH
- Subjects
- Amino Acid Sequence, Animals, Blood Bactericidal Activity immunology, Chickens, Complement Activation immunology, Complement C3 antagonists & inhibitors, Complement C3 physiology, Complement C3b antagonists & inhibitors, Complement Pathway, Alternative immunology, Dogs, Extracellular Fluid immunology, Gram-Positive Bacterial Infections enzymology, Gram-Positive Bacterial Infections immunology, Gram-Positive Bacterial Infections microbiology, Guinea Pigs, Humans, Hydrolysis, Mice, Molecular Sequence Data, Neutrophils immunology, Phagocytosis immunology, Complement C3 metabolism, Complement C3b metabolism, Enterococcus faecalis enzymology, Enterococcus faecalis immunology, Extracellular Fluid enzymology, Gelatinases physiology
- Abstract
Enterococcus faecalis (Ef) accounts for most cases of enterococcal bacteremia, which is one of the principal causes of nosocomial bloodstream infections (BSI). Among several virulence factors associated with the pathogenesis of Ef, an extracellular gelatinase (GelE) has been known to be the most common factor, although its virulence mechanisms, especially in association with human BSI, have yet to be demonstrated. In this study, we describe the complement resistance mechanism of Ef mediated by GelE. Using purified GelE, we determined that it cleaved the C3 occurring in human serum into a C3b-like molecule, which was inactivated rapidly via reaction with water. This C3 convertase-like activity of GelE was shown to result in a consumption of C3 and thus inhibited the activation of the complement system. Also, GelE was confirmed to degrade an iC3b that was deposited on the Ag surfaces without affecting the bound C3b. This proteolytic effect of GelE against the major complement opsonin resulted in a substantial reduction in Ef phagocytosis by human polymorphonuclear leukocytes. In addition, we verified that the action of GelE against C3, which is a central component of the complement cascade, was human specific. Taken together, it was suggested that GelE may represent a promising molecule for targeting human BSI associated with Ef.
- Published
- 2008
- Full Text
- View/download PDF